重塑Lifesciences第二季度每股收益（0.06）同比（1.08）美元，销售额197万美元，低于221万美元的预期

Reshape Lifesciences (NASDAQ: RSLS) reported quarterly losses of $(0.06) per share. This is a 94.44 percent increase over losses of $(1.08) per share from the same period last year. The company reported quarterly sales of $1.97 million which missed the analyst consensus estimate of $2.21 million by 11.09 percent. This is a 12.82 percent decrease over sales of $2.25 million the same period last year.